RICH1 is a novel key suppressor of isoproterenol‑ or angiotensin II‑induced cardiomyocyte hypertrophy

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Cell Signaling

Background:

• Cardiac hypertrophy is a critical precursor to heart failure.
• Small GTPases and GTPase-activating proteins (GAPs) are key regulators of cardiac hypertrophy.
• The specific role of RhoGAP interacting with CIP4 homologs protein 1 (RICH1) in cardiac hypertrophy is currently unknown.

Purpose of the Study:

• To investigate the role of RICH1 in cardiomyocyte hypertrophy.
• To determine if RICH1 expression is altered during hypertrophy induction.
• To assess the functional impact of RICH1 modulation on hypertrophic responses.

Main Methods:

• Utilized H9c2 cells treated with isoproterenol (ISO) or angiotensin II (Ang II) to model cardiac hypertrophy.
• Assessed cell viability using Cell Counting Kit-8 assay and cell surface area (CSA) via fluorescence staining.
• Quantified mRNA levels of hypertrophic markers (Nppa, Nppb, Myh7) using RT-qPCR and protein levels of RICH1 via Western blotting.

Main Results:

• RICH1 expression was downregulated in ISO- or Ang II-treated H9c2 cells.
• Overexpression of RICH1 attenuated ISO/Ang II-induced upregulation of hypertrophic markers and CSA enlargement.
• Knockdown of RICH1 exacerbated these hypertrophic responses.

Conclusions:

• RICH1 acts as a novel suppressor of ISO- or Ang II-induced cardiomyocyte hypertrophy.
• RICH1's regulatory role in F-actin dynamics and cell adhesion may contribute to its cardioprotective function.
• Further research into RICH1 and its downstream pathways could yield new therapeutic strategies for inhibiting cardiac hypertrophy.